George Weinstock has become a professor of genetics at Washington University in St. Louis, as well as associate director of the university’s Genome Sequencing Center, In Sequence has learned. He started his new appointment in January. Weinstock comes to Wash U from Baylor College of Medicine, where he was a professor in the departments of molecular and human genetics and molecular virology and microbiology, and co-director of the Human Genome Sequencing Center. He holds a PhD microbiology from the Massachusetts Institute of Technology and a BS in biophysics from the University of Michigan.
Bo Fishback has become vice president of entrepreneurship at the Kauffman Foundation, the organization said last week. He is a co-founder of LightSpeed Genomics, a startup company that is developing next-generation DNA sequencing technology (see Short Reads in this issue). Fishback joined the foundation in 2006 as a director in the advancing innovation area. Last year, he joined BioMed Valley Discoveries, a translational research and development organization based in Kansas City that is affiliated with the Stowers Institute. Fishback holds an MBA from the Harvard Business School and a BSc in biomedical engineering from Southern Methodist University.
Elisabeth Allison has joined the board of directors of Helicos BioSciences, the company said last week. She is a partner at Anzi Partners, a business consulting firm specializing in development and negotiation of joint ventures, strategic alliances, and broad-based licensing agreements. At Anzi, she is chief negotiator for publishing, media, and software ventures for long-term clients. Allison holds a PhD in business economics from the Harvard Business School and the Harvard Economics Department, as well as a BA from Harvard College.
Noel Doheny has become CEO of OpGen, the company said last week. He also joined OpGen’s board of directors. Most recently, Doheny was senior vice president of molecular diagnostics at Affymetrix. Previously, he held positions at Ciba-Corning, Biostar, and Qiagen.
Jerry Williamson has become president of US operations at Genetix, a new position, the company said last week. Previously, he was president of Biacore and president of Pyrosequencing. He has also held management positions at Genzyme Genetics and Roche Laboratories.